BridgeMD
New treatment option for Anterior Cruciate Ligament Injuries
Official title How to Best Treat Anterior Cruciate Ligament Injuries
ClinicalTrials.gov ID: NCT04770233
What this study is testing
- What it's testing
- The project is a pragmatic registry-based RCT aiming to investigate ACL injury treatment. Study results will help fill knowledge gaps, facilitate shared decision making and strengthen patient treatment.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 16 to 50
You may be able to join if
- Patients who have sustained an acute ACL injury (must be possible to perform the "early surgery" treatment option within 12 weeks)
- Age 16-50 years and skeletally mature
- No previous surgery in the index knee or knee injury which influences rehabilitation
- Patient capable to undergo both surgery and rehabilitation
You likely can't join if
- Elite athletes (Tegner 10) in pivoting sports and patients with additional knee injuries warranting repair
The study team makes the final eligibility decision.
Where it's taking place
- Lørenskog, Akershus, Norway
- Oslo, Norway
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 16 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lørenskog, Akershus, Norway; Oslo, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.